Diehard Bargain Hunter: Phillips 66 (PSX), Exelixis Inc. (EXEL)

You should consider shares of Phillips 66 (NYSE:PSX) and Exelixis Inc. (NASDAQ:EXEL) if you are looking for a great stocks to invest in. Starting with the PSX shares, which traded at $112.75 at the close of the recent session, dropping -1.38%. On Tuesday, the company’s shares shed -$1.58 from its value which represented in intraday trading. The stock is now 20.56% higher in year-to-date (YTD) trading. PSX’s intraday high was $113.68 while its lowest price touched $112.42. The stock’s 52-week high price is $119.92, which means the current price is at -5.98%. In terms of trading activity, the daily trading volume rose to 4128395 against 200-day average trading volume of 2,560,787 shares.

What are analyst forecasts for Phillips 66 (NYSE:PSX)?

At a consensus rating of 4.38, PSX is trending as a streaking Moderate Buy, as it has been the case a month ago when 13 analysts called it a Moderate Buy. Two months ago, 14 analysts recommended, on average, that PSX stock is a Moderate Buy. The Basic Materials company’s shares’ overall bearish trend saw it close higher on Tuesday compared to its opening price of $113.68 on the day.

Forecasts for Phillips 66 (NYSE:PSX) give the stock a fair value for the growth of 12.93% from its last price. The 12-month price forecast for the stock by analysts puts the stock’s mean price target at $129.50, which means the price per share could rise by nearly $16.75. The price range target is between a low of $110.00 and a high of $143.00. The stock would need to gain by about $21.15 to hit the estimated high or 0.7% from its 12-month low.

The consensus among 20 analysts is that it is a good time for one to Overweight in the Phillips 66. 12 analysts rate PSX as a Buy, with 0 of 20 analysts rate it as a Sell. 2 have valued the stock as Overweight and 6 have recommended that investors Hold.

Phillips 66 (NYSE:PSX) Upgrades and Downgrades

In terms of rating changes, Cowen on November 07, 2019, Reiterated Phillips 66 (PSX) at Outperform. They believe the stock could reach $130 in the near term. Analysts at Evercore ISI have assigned a Outperform rating for the stock in their research note on October 02, 2019 with an estimated price target of $135. Moreover, Macquarie analysts issued a rating of Outperform for the stock on September 05, 2019. On July 26, 2019, the stock earned a Outperform rating due to an analyst call from Cowen, while analysts from Citigroup on June 21, 2019 suggested that the stock is Buy.

Exelixis Inc. (NASDAQ:EXEL) adds -$0.03 on Tuesday

The EXEL stock has tanked -15.25% year-to-date and is currently trading at $16.67, which is -34.14% below its 52-week high. The company shares lost -0.18% on the day and have risen nearly 10.99% off a low hit. At current levels, Exelixis Inc. has a valuation of about $956.10M. As of 12/03/19, this stock has fallen -0.66% during the week and closed at $16.70 in the previous session. However, recent Exelixis Inc. stock performance shows that EXEL shares are 4.12% up over the last month, and -13.81% down for the last three months.

Earnings per share (EPS) estimates for the current quarter are $0.23, with the trailing 12-month share earnings at $1.96. The ratio is expected to be down by -57.90% for the current year 2019 and 1.10% for next year. Over the next 5-year period, earnings per share will be 46.00%. But will the EXEL stock surprise in the current quarter results, where the $0.31 actual EPS reported on 9/29/2019 surprised by 63.20% or was higher by $0.12 from the estimated $0.19.

Sales Growth to climb 6.10% for the year

How well will Exelixis Inc. perform as a business over the current quarter, year and next 5-year period? Compared to the year-ago quarter, analysts forecast the company to bring in between $213.9M and $254.86M in current quarter sales. The consensus estimated for the current quarter is $234.9M from sales. Forecasts for this fiscal year are between $941.4M and $983.73M and the consensus estimate for sales is at $961.59M. EXEL has its next quarter sales estimates at between $224.1M and $310M, with the quarter-over-quarter growth estimates at 13.90% and the annual growth forecast for the year at 6.10%.

Who owns shares in Exelixis Inc. (EXEL)?

Let’s briefly focus on the share ownership of the Exelixis Inc. (NASDAQ:EXEL) stock, where we find that 77.24% of shares are held by institutions. Blackrock Inc. tops the list of institutional owners as it is holding 30.74 million shares or 10.12% of shares outstanding. Vanguard Group, Inc. (The) and Meditor Group Ltd held 28.1 million and 15.0 million representing 9.25% and 4.94% respectively at the close of the last trading session. As of Sep 29, 2019, Renaissance Technologies, LLC accounted for 14.85 million shares at over 262.62 million. This represented 4.89% of shares outstanding. FMR, LLC held 12.96 million shares at over 229.23 million representing 4.27% of shares outstanding.

EXEL Insider Activity

Insider activity can also give a signal in terms of price direction. Looking at Exelixis Inc. (EXEL), a total of 797416 shares have been sold by insiders over the last 6 months while 822376 shares were added in the same time span. On 2/14/2019, Director by the name Cohen Charles M sold 100000.0 shares worth $2.2 million at the price of $22.41 per share. Filings also show that Cohen Charles M sold a total of 100000.0 shares on 2/15/2019 valued at $2.2 million. Since the last insider activity, the company’s share price has dropped -24.98%.